Skip to main content
ACS Pharmacology & Translational Science logoLink to ACS Pharmacology & Translational Science
. 2022 Jun 9;5(7):512. doi: 10.1021/acsptsci.2c00094

Correction to “Prolyl Hydroxylase Domain Protein Inhibitor Not Harboring a 2-Oxoglutarate Scaffold Protects against Hypoxic Stress”

Kento Sonoda, Sudarma Bogahawaththa, Akito Katayama, Saki Ujike, Sae Kuroki, Naho Kitagawa, Kohichi Hirotsuru, Norio Suzuki, Toshio Miyata, Shin-ichi Kawaguchi, Tadayuki Tsujita
PMCID: PMC9274765  PMID: 35837134

Due to a production error, this paper was published in volume 5, issue 5, before the final corrections had been incorporated.

Notably, on pages 362 and 369, the surname of the second author is corrected, from “Bogahawattha” to “Bogahawaththa”, and an additional affiliation is given for the eighth author, Norio Suzuki: Applied Oxygen Physiology Project, New Industry Creation Hatchery Center (NICHe), Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.

Additional changes are made in notations throughout the text, none of which has a significant impact on the scientific content or the conclusions of the paper.

The online version of the original paper has been updated to reflect these final corrections.


Articles from ACS Pharmacology & Translational Science are provided here courtesy of American Chemical Society

RESOURCES